Hermetica editorial standard
NAD+ (Nicotinamide Adenine Dinucleotide)
Claim review in progress
NAD+ (Nicotinamide Adenine Dinucleotide) is retained as a structured identity record in the Vitamin collection. Its medical, efficacy, dosage, safety, citation, and product claims are withheld until accountable human review is complete.
- Category
- Vitamin
- Publication state
- legacy_published
- Review state
- unreviewed
- Record key
- nad-nicotinamide-adenine-dinucleotide
- Source name
- NAD+ (Nicotinamide Adenine Dinucleotide)
- Record type
- nucleotide
- Alternate names
- Nicotinamide adenine dinucleotide, NAD, Coenzyme I, DPN, Diphosphopyridine nucleotide, β-Nicotinamide adenine dinucleotide, Nadide
- External identity candidate
- Q26987253 (mapping pending review)
- Record updated
What this identity page provides
A stable canonical URL, source label, category placement, alternate-name index, review status, and links to neighboring identity records. These fields support entity discovery without presenting unreviewed health claims as fact.
Related identity records
Review our methodology and editorial policy, browse the public ingredient index, or return after review is complete.